Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-delicate medications, such devices which includes a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with quite low permeability to oxygen and comprises